glp-1 physiology informs the pharmacotherapy of obesity

glp-1 physiology informs the pharmacotherapy of obesity glp 1 Advances in physiology, design and development of novel medications changing the landscape of obesity pharmacotherapy GLP-1 Agonists For Obesity In

Name: glp-1 physiology informs the pharmacotherapy of obesity glp 1 Advances in physiology, design and development of novel medications changing the landscape of obesity pharmacotherapy GLP-1 Agonists For Obesity In
Brand: inmobiliariafranchi.com
SKU: 71809817937
Price: 26.24 USD
Availability: InStock
Rating: 4.8127 (7 reviews)

SKU: 71809817937

4.8

USD26.24 USD68.24

Pay in 4 interest-free payments of $6.56 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 29 - Sep 3

Description

The article presents it as the first GLP-1 agonist cleared by the FDA, well before any weight-management indication existed

Amino Acids, 49(12), 20912098

A practical guide to statistical power and sample size calculations in R

doi:10.1038/s12276-018-0183-1 131

GLP-1 infusion in a patient with Cushings disease induced diabetes has indeed demonstrated similar insulinotropic, glucagonostatic and glucose-lowering actions as in patients with type 2 diabetes (31)